APA (7th ed.) Citation

AL, L., A, S., Y, H., A, S., S, S., & M, A. (2026). Metabolic profile alterations as early indicators of gastrointestinal stromal tumors (GISTs) recurrence and imatinib resistance. Journal of gastrointestinal oncology, 17(3), 139. https://doi.org/10.21037/jgo-2026-1-0182

Chicago Style (17th ed.) Citation

AL, Luo, Seylani A, Haile Y, Sadighian A, Sadighian S, and Agulnik M. "Metabolic Profile Alterations as Early Indicators of Gastrointestinal Stromal Tumors (GISTs) Recurrence and Imatinib Resistance." Journal of Gastrointestinal Oncology 17, no. 3 (2026): 139. https://doi.org/10.21037/jgo-2026-1-0182.

MLA (9th ed.) Citation

AL, Luo, et al. "Metabolic Profile Alterations as Early Indicators of Gastrointestinal Stromal Tumors (GISTs) Recurrence and Imatinib Resistance." Journal of Gastrointestinal Oncology, vol. 17, no. 3, 2026, p. 139, https://doi.org/10.21037/jgo-2026-1-0182.